Publications by authors named "Yongjun Xue"

Claim this Profile
E
Exposure-response relationship of fedratinib in patients with intermediate-2 or high-risk myelofibrosis.
Yizhe Chen, Yan Li, Yongjun Xue, Patrick Brown, Christopher Hernandez

Br J Clin Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1β-Hydroxydeoxycholic acid as an endogenous biomarker in human plasma for assessment of drug-drug interaction with moderate CYP3A inhibitor.
Yizhe Chen, Runlan Huo, Brian Melo, Jim X Shen, Ken Ogasawara, Yongjun Xue

Drug Metab Dispos· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).
Andrew M Riselli, Sook Wah Yee, Jia Yang, Claire M Brett, Kelsey Trumbach, Yongjun Xue

Clin Pharmacol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.
Yizhe Chen, Richard A Preston, Thomas Marbury, William B Smith, Massimo Attanasio, Yongjun Xue

Cancer Chemother Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the utility of endogenous OCT2 and MATE1/2-K biomarkers for DDI assessment in early clinical settings.
Rina Nishii, Yongjun Xue, Runlan Huo, Jian Chen, Hong Shen

J Pharm Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry ( - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV).
John Wojcik, Timothy Sikorski, Jian Wang, Yue Huang, Hiroshi Sugimoto, Yongjun Xue

Bioanalysis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population pharmacokinetic analysis to evaluate the impact of renal impairment on the pharmacokinetics of iberdomide.
Ping Chen, Hongxia Lin, Yongjun Xue, Mark Thomas, Alice Wang

J Pharm Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1β-Hydroxydeoxycholic Acid as an Endogenous Biomarker in Human Plasma for Assessment of CYP3A Clinical Drug-Drug Interaction Potential.
Yongjun Xue, Linna Wang, Runlan Huo, Mu Chen, Brian Melo

Drug Metab Dispos· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gradient Hierarchically Porous Ionic-Junction Fibers of Wet-Spun Carboxymethyl Cellulose Coagulated with Copper Sulfate.
Yongjun Xue, Hua Zhang, Fan Su, Lu Zhang, Gaoyuan Lang

Biomacromolecules· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants.
Hong Shen, Runlan Huo, Yueping Zhang, Linna Wang, Nian Tong, Yongjun Xue

J Pharmacol Exp Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine).
Mike Baratta, Wenying Jian, Shawna Hengel, Surinder Kaur, Jennifer Cunliffe, Yongjun Y-J Xue

Bioanalysis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults.
Yizhe Chen, David Wyatt, Massimo Attanasio, Mark Thomas, Michael Thomas, Yongjun Xue

Cancer Chemother Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Dimentional printing of polysaccharides for water-treatment: A review.
Hua Zhang, Yongjun Xue, Chenyu Jiang, Dagang Liu, Lu Zhang

Int J Biol Macromol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.
Jessica Chu, Erika Panfen, Linna Wang, Anthony Marino, Xue-Qing Chen, Yongjun Xue

Pharm Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Iberdomide.
Yiming Cheng, Allison Gaudy, Liangang Liu, Ying Ye, Michael Thomas, Yongjun Xue

Clin Pharmacol Drug Dev· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( - Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine).
Matt Szapacs, Wenying Jian, Daniel Spellman, Jennifer Cunliffe, Elizabeth Verburg, Yongjun Xue

Bioanalysis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo.
Yueping Zhang, Petia A Shipkova, Bethanne M Warrack, David M Nelson, Linna Wang, Xue-Qing Chen, Yongjun Xue

Drug Metab Dispos· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Propionate poses antivirulence activity against Botrytis cinerea via regulating its metabolism, infection cushion development and overall pathogenic factors.
Chuanxi Zhu, Yan Tang, Dandan Ren, Weiheng Ren, Yongjun Xue

Food Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White Collar 1 Modulates Oxidative Sensitivity and Virulence by Regulating the HOG1 Pathway in Fusarium asiaticum.
Ying Tang, Yan Tang, Dandan Ren, Congcong Wang, Yao Qu, Yongjun Xue

Microbiol Spectr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of varying amounts of different biochars on mercury methylation in paddy soils and methylmercury accumulation in rice (Oryza sativa L.).
Yongjie Wang, Li Chen, Yuanyuan Chen, Yongjun Xue, Guangxia Liu

Sci Total Environ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macroscopic Spiral Patterns of Cholesteric Cellulose Nanocrystals Induced by Chiral Doping and Vortex Flowing.
Mengna Guo, Qin Li, Ruimin Xiao, Dagang Liu, Yongqing Cai, Yongjun Xue

Biomacromolecules· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects.
Yiming Cheng, Ying Ye, Allison Gaudy, Atalanta Ghosh, Yongjun Xue

Clin Pharmacol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based analysis for the population pharmacokinetics of iberdomide and its major active metabolite in healthy subjects and patients with relapsed and refractory multiple myeloma.
Yiming Cheng, Yongjun Xue, Lu Chen, Mark Masin, Paulo Maciag

Br J Clin Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fluconazole on the pharmacokinetics of a single dose of fedratinib in healthy adults.
Yizhe Chen, Ken Ogasawara, Rebecca Wood-Horrall, Mark Thomas, Michael Thomas, Yongjun Xue

Cancer Chemother Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton's Tyrosine Kinase Inhibitor.
Yiming Cheng, Liangang Liu, Yongjun Xue, Simon Zhou, Yan Li

Eur J Drug Metab Pharmacokinet· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis